| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K52037352 |
| PharmacoGx | BRD-K52037352 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TINCR | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | KRT2 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | LARP4 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | VWC2 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | NFATC2IP | CTRPv2 | pan-cancer | AAC | 0.09 | 0.04 |
| mRNA | TADA3 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | MED12L | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | ATP5A1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.04 |
| mRNA | ZNF232 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | LCE1C | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
